Role of Macrophage Costimulatory Molecules in Polymicrobial Sepsis
巨噬细胞共刺激分子在多种微生物脓毒症中的作用
基本信息
- 批准号:7211817
- 负责人:
- 金额:$ 38.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-01-15 至 2011-12-31
- 项目状态:已结题
- 来源:
- 关键词:Anti-Inflammatory AgentsAnti-inflammatoryBindingBiologicalBiological MarkersCD14 geneCD28 geneCD40 AntigensCD80 geneCTLA4 geneCellsCellular ImmunityClassDNA BindingDataDiseaseDisease MarkerGoldHumanImmuneImmune responseImmunityIn VitroIndividualInflammationInflammatoryInflammatory ResponseInterleukin-10Interleukin-6InvestigationKineticsKnockout MiceLigandsLigationMacrophage ActivationMediatingModelingMolecular ProfilingMononuclearMusNF-kappa BNatural ImmunityOutcomePathway interactionsPatientsPhasePlasmaPlayProductionProtein IsoformsPuncture procedureRegulationReportingResearch PersonnelRoleSepsisSeptic ShockSeveritiesSurvivorsSystemT-LymphocyteTLR4 geneTNFRSF5 geneTNFSF5 geneTestingUp-Regulationattenuationchemokinecytokineimprovedin vivointercellular cell adhesion moleculemacrophagemonocytemortalityneutrophilnovelpathogenprogramsreceptorseptic
项目摘要
DESCRIPTION (provided by applicant): Inflammation in sepsis is controlled primarily by the degree of macrophage activation. Costimulatory molecules are a class of receptors capable of macrophage activation in adaptive immunity. Ligation of macrophage expressed CD40, CD80/CD86 and ICAM by CD154, CD28/CTLA4 and LFA-1 on activated T- cells, increases NF-kB DNA binding and the ratio of stimulatory/inhibitory isoforms of C/EBPb. This results in increased production of numerous inflammatory cytokines. However, the role for costimulatory molecules in the innate immune response during polymicrobial sepsis is not well described. We recently described CD40- /- mice have delayed mortality with polymicrobial sepsis with attenuations in NF-kB activity and the ratio of stimulatory/inhibitory C/EBPb. We now present data that neutrophils, a main component of innate immune response in sepsis, can directly activate macrophages via engagement of the costimulatory molecules CD40, CD80/CD86 and ICAM in vitro. In vivo, CD80/CD86-/- mice have improved survival compared to WT mice after CLP. This was associated with a reduction in NF-kB, the ratio of stimulatory/inhibitory C/EBPb and levels of IL-6 and IL-10 in BAL and plasma. Similar to what has been reported in moels of adaptive immunity, inhibtion for multiple costimulatory molecules provided additional benefit. Both CD40/CD80/CD86-/- mice and ICAM neutralization in CD80/CD86-/- mice improved survival compared to CD80/86-/- mice after CLP. In humans with sepsis, we found upregulation of PMN expressed CD28, CTLA4 and CD154, and monocyte expressed CD40, CD80/CD86 and ICAM compared to healthy controls. In addition, the soluble isoforms of CD154, CD28, ICAM and CTLA4 were upregulated in septic patients compared to healthy controls. Furthermore, levels of sCD28 and sCD154 were only upregulated in non-survivors, suggesting a potential role as a biomarker of disease activity. Together, these results suggest an important role for costimulatory molecules in sepsis. In this proposal we plan to extend these observations to: 1. Characterize the kinetics and activity of the CD40-CD154, CD80/CD86-CD28/CTLA4 and ICAM-LFA-1 systems in a murine model of polymicrobial sepsis, 2. Test the effect of inhibition of multiple costimulatory molecules in sepsis via a novel CD40/CD80/CD86-/- mouse, and 3. To fully assess the significance of costimulatory molecule expression and activity both in vivo and ex vivo in humans with sepsis and septic shock
描述(由申请人提供):脓毒症中的炎症主要由巨噬细胞活化程度控制。共刺激分子是一类在获得性免疫中能够激活巨噬细胞的受体。通过活化的T细胞上的CD 154、CD 28/CTLA 4和LFA-1连接表达CD 40、CD 80/CD 86和ICAM的巨噬细胞,增加NF-κ B DNA结合和C/EBPb的刺激/抑制同种型的比率。这导致许多炎性细胞因子的产生增加。然而,共刺激分子在多微生物脓毒症的先天性免疫反应中的作用还没有得到很好的描述。我们最近描述了CD 40- /-小鼠在多微生物脓毒症中具有延迟的死亡率,其中NF-kB活性和刺激性/抑制性C/EBPb的比率减弱。我们现在提供的数据表明,中性粒细胞,在脓毒症中的先天性免疫反应的主要组成部分,可以直接激活巨噬细胞通过参与的共刺激分子CD 40,CD 80/CD 86和ICAM在体外。在体内,CLP后,与WT小鼠相比,CD 80/CD 86-/-小鼠的存活率有所改善。这与BAL和血浆中NF-kB、刺激性/抑制性C/EBPb比值以及IL-6和IL-10水平的降低相关。类似于在获得性免疫的分子中所报道的,对多种共刺激分子的抑制提供了额外的益处。CLP后,与CD 80/86-/-小鼠相比,CD 40/CD 80/CD 86-/-小鼠和CD 80/CD 86-/-小鼠中的ICAM中和均改善了存活率。在脓毒症患者中,我们发现与健康对照相比,PMN表达CD 28、CTLA 4和CD 154,单核细胞表达CD 40、CD 80/CD 86和ICAM。此外,与健康对照相比,脓毒症患者中可溶性同种型CD 154、CD 28、ICAM和CTLA 4上调。此外,sCD 28和sCD 154的水平仅在非幸存者中上调,表明其作为疾病活动的生物标志物的潜在作用。总之,这些结果表明,共刺激分子在脓毒症中的重要作用。在本提案中,我们计划将这些观察扩展到:1。在多微生物败血症的鼠模型中表征CD 40-CD 154、CD 80/CD 86-CD 28/CTLA 4和ICAM-LFA-1系统的动力学和活性,2.通过新的CD 40/CD 80/CD 86-/-小鼠测试多种共刺激分子的抑制在脓毒症中的作用,和3.全面评估体内和体外共刺激分子表达和活性在脓毒症和脓毒性休克患者中的意义
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEFFREY A. GOLD其他文献
JEFFREY A. GOLD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEFFREY A. GOLD', 18)}}的其他基金
A Turn-Key EHR Simulation Program to Reduce Diagnostic Error in Ambulatory Care
交钥匙 EHR 模拟程序可减少门诊护理中的诊断错误
- 批准号:
10005345 - 财政年份:2019
- 资助金额:
$ 38.44万 - 项目类别:
A Turn-Key EHR Simulation Program to Reduce Diagnostic Error in Ambulatory Care
交钥匙 EHR 模拟程序可减少门诊护理中的诊断错误
- 批准号:
10470775 - 财政年份:2019
- 资助金额:
$ 38.44万 - 项目类别:
A Turn-Key EHR Simulation Program to Reduce Diagnostic Error in Ambulatory Care
交钥匙 EHR 模拟程序可减少门诊护理中的诊断错误
- 批准号:
10242662 - 财政年份:2019
- 资助金额:
$ 38.44万 - 项目类别:
Creation and validation of a training toolkit to ensure safe and proficient use of EHR by medical scribes
创建和验证培训工具包,以确保医疗抄写员安全、熟练地使用 EHR
- 批准号:
9284346 - 财政年份:2017
- 资助金额:
$ 38.44万 - 项目类别:
Creation and validation of a training toolkit to ensure safe and proficient use of EHR by medical scribes
创建和验证培训工具包,以确保医疗抄写员安全、熟练地使用 EHR
- 批准号:
10225286 - 财政年份:2017
- 资助金额:
$ 38.44万 - 项目类别:
Creation and validation of a training toolkit to ensure safe and proficient use of EHR by medical scribes
创建和验证培训工具包,以确保医疗抄写员安全、熟练地使用 EHR
- 批准号:
9750123 - 财政年份:2017
- 资助金额:
$ 38.44万 - 项目类别:
Use of Simulation to improve use and safety of Electronic Health Records
使用模拟来提高电子健康记录的使用和安全性
- 批准号:
8414070 - 财政年份:2012
- 资助金额:
$ 38.44万 - 项目类别:
Use of Simulation to improve use and safety of Electronic Health Records
使用模拟来提高电子健康记录的使用和安全性
- 批准号:
8540415 - 财政年份:2012
- 资助金额:
$ 38.44万 - 项目类别:
Use of Simulation to improve use and safety of Electronic Health Records
使用模拟来提高电子健康记录的使用和安全性
- 批准号:
8698771 - 财政年份:2012
- 资助金额:
$ 38.44万 - 项目类别:
Role of Macrophage Costimualtory Molecules in Polymicrobial Sepsis
巨噬细胞共刺激分子在多种微生物脓毒症中的作用
- 批准号:
7339019 - 财政年份:2007
- 资助金额:
$ 38.44万 - 项目类别:
相似海外基金
Anti-inflammatory Signaling of RNA-binding Protein, Tristetraprolin, During Myocardial Infarction
RNA 结合蛋白 Tristetraprolin 在心肌梗死期间的抗炎信号传导
- 批准号:
10644962 - 财政年份:2023
- 资助金额:
$ 38.44万 - 项目类别:
Characterization of the expression and anti-inflammatory properties of human calcium-binding protein spermatid-associated 1 in serum and saliva
血清和唾液中人钙结合蛋白精子细胞相关 1 的表达和抗炎特性的表征
- 批准号:
565154-2021 - 财政年份:2021
- 资助金额:
$ 38.44万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
The effect of RNA binding proteins on regulatory mechanisms of anti-fibrotic and anti-inflammatory miRNA biogenesis
RNA结合蛋白对抗纤维化和抗炎miRNA生物发生调节机制的影响
- 批准号:
19K16523 - 财政年份:2019
- 资助金额:
$ 38.44万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The anti-inflammatory mRNA-binding protein ZFP36 in Obesity and Metabolism
抗炎 mRNA 结合蛋白 ZFP36 在肥胖和代谢中的作用
- 批准号:
8449108 - 财政年份:2012
- 资助金额:
$ 38.44万 - 项目类别:
The anti-inflammatory mRNA-binding protein ZFP36 in Obesity and Metabolism
抗炎 mRNA 结合蛋白 ZFP36 在肥胖和代谢中的作用
- 批准号:
8636465 - 财政年份:2012
- 资助金额:
$ 38.44万 - 项目类别:
The anti-inflammatory mRNA-binding protein ZFP36 in Obesity and Metabolism
抗炎 mRNA 结合蛋白 ZFP36 在肥胖和代谢中的作用
- 批准号:
8606955 - 财政年份:2012
- 资助金额:
$ 38.44万 - 项目类别:
The anti-inflammatory mRNA-binding protein ZFP36 in Obesity and Metabolism
抗炎 mRNA 结合蛋白 ZFP36 在肥胖和代谢中的作用
- 批准号:
8237236 - 财政年份:2012
- 资助金额:
$ 38.44万 - 项目类别:
The anti-inflammatory mRNA-binding protein ZFP36 in Obesity and Metabolism
抗炎 mRNA 结合蛋白 ZFP36 在肥胖和代谢中的作用
- 批准号:
8824524 - 财政年份:2012
- 资助金额:
$ 38.44万 - 项目类别:
Nucleic Acid Binding Polymers as Anti-Inflammatory Agents
作为抗炎剂的核酸结合聚合物
- 批准号:
8309507 - 财政年份:2011
- 资助金额:
$ 38.44万 - 项目类别:
Modulation of tissue regeneration by the glycosaminoglycan-binding anti-inflammatory cytokine interleukin-10 (B09)
糖胺聚糖结合抗炎细胞因子白细胞介素 10 (B09) 对组织再生的调节
- 批准号:
173975957 - 财政年份:2010
- 资助金额:
$ 38.44万 - 项目类别:
CRC/Transregios














{{item.name}}会员




